Lead, Vaccine Formulation Laboratory, University of Lausanne
Nicolas Collin holds a Doctorate in Veterinary Medicine from the National Veterinary School of Toulouse, France, and a PhD in Molecular Microbiology from University Paul Sabatier of Toulouse. He worked as project leader in the biotech industry (Transgene) then did a visiting fellowship at the National Institutes of Health (NIH) in Washington DC, USA, where he worked on vaccines against canine Leishmaniasis.
In 2008, Dr Collin joined the World Health Organization Headquarters (Geneva, Switzerland) as technical officer on influenza vaccines. During the pandemic influenza of 2009, he served as coordinator of the WHO pandemic H1N1 vaccine task force.
Dr Collin has been leading the Vaccine Formulation Laboratory (VFL) at University of Lausanne since its inception in 2010. Created under the auspices of WHO, the VFL is a platform providing access to adjuvants and formulation expertise for the scientific community, with a special focus to the public sector and Under-Resourced countries.